144 related articles for article (PubMed ID: 28011578)
1. Prognostic implications of
Knief J; Reddemann K; Lazar-Karsten P; Herhahn T; Petrova E; Wellner U; Thorns C
J Clin Pathol; 2017 Mar; 70(3):274-276. PubMed ID: 28011578
[No Abstract] [Full Text] [Related]
2. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Huang L; Xu AM; Peng Q
Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
[TBL] [Abstract][Full Text] [Related]
4. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.
Chen Y; Jin M; Shao Y; Xu G
Dis Markers; 2019; 2019():4659048. PubMed ID: 31781301
[TBL] [Abstract][Full Text] [Related]
6. The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma.
Dong H; Guo H; Xie L; Wang G; Zhong X; Khoury T; Tan D; Zhang H
PLoS One; 2013; 8(5):e62986. PubMed ID: 23671646
[TBL] [Abstract][Full Text] [Related]
7. Survival prediction with neuroendocrine differentiation?
Fricker J
Lancet Oncol; 2006 Nov; 7(11):891. PubMed ID: 17099980
[No Abstract] [Full Text] [Related]
8. Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1.
Zhang LH; Huang Q; Fan XS; Wu HY; Yang J; Feng AN
Pathol Res Pract; 2013 Oct; 209(10):611-7. PubMed ID: 24035280
[TBL] [Abstract][Full Text] [Related]
9. Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.
Jin Z; Holubek M; Sukov WR; Sattler CA; Wiktor AE; Jenkins RB; Wu TT; Yoon HH
Am J Clin Oncol; 2019 Feb; 42(2):190-195. PubMed ID: 30516569
[TBL] [Abstract][Full Text] [Related]
10. SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.
Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Kuteeva E; Johannesson H; Jirström K; Eberhard J
Virchows Arch; 2014 Dec; 465(6):649-59. PubMed ID: 25326863
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
[TBL] [Abstract][Full Text] [Related]
12. [Adenocarcinoma of the gastro-esophageal junction].
Huang Q; Fan XS; Shi J; Zhang YF; Feng AN; Wu HY; Sun Q; Zhou Q; Yu HP; Meng FQ; Wang JM
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):793-5. PubMed ID: 23324225
[No Abstract] [Full Text] [Related]
13. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
14. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.
Streppel MM; Vincent A; Mukherjee R; Campbell NR; Chen SH; Konstantopoulos K; Goggins MG; Van Seuningen I; Maitra A; Montgomery EA
Hum Pathol; 2012 Oct; 43(10):1755-63. PubMed ID: 22542127
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
17. Expression of β-catenin and its correlation with metastatic progression of esophagogastric junction adenocarcinoma.
Wlodarczyk J; Rudnicka-Sosin L; Kużdżał J
Pol J Pathol; 2015 Dec; 66(4):414-9. PubMed ID: 27003775
[TBL] [Abstract][Full Text] [Related]
18. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.
Taniere P; Borghi-Scoazec G; Saurin JC; Lombard-Bohas C; Boulez J; Berger F; Hainaut P; Scoazec JY
Am J Surg Pathol; 2002 Sep; 26(9):1213-21. PubMed ID: 12218578
[TBL] [Abstract][Full Text] [Related]
20. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.
Deans DA; Wigmore SJ; Gilmour H; Paterson-Brown S; Ross JA; Fearon KC
Br J Cancer; 2006 Dec; 95(11):1568-75. PubMed ID: 17088911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
